Affimed NV (STU:A28A)
€ 3.5 -0.04 (-1.13%) Market Cap: 55.46 Mil Enterprise Value: 34.65 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 36/100

Q1 2020 Affimed NV Earnings Call Transcript

Jun 23, 2020 / 12:30PM GMT
Release Date Price: €38.74 (-3.27%)
Operator

Good day, and welcome to Affimed's First Quarter 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions). As a reminder, today's conference is being recorded. I will now introduce your host for today's conference, Alexander Fudukidis, Head of Investor Relations at Affimed. Please go ahead.

Alexander Fudukidis
Affimed N.V. - Head of IR

Thank you, Bernard. I'd like to welcome and thank you all for joining us today for Affimed's first quarter 2020 financial results and operational progress. This morning, Affimed issued a press release, which is also posted on our website at www.affimed.com.

On the call today, we have with us Drs. Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; and Arndt Schottelius, Chief Medical (sic) [Scientific] Officer; and Michael Wolf, Head of Finance. We are also joined by Dr. Wolfgang Fischer, Chief Operating Officer; and Ms. Denise Mueller, Chief Business Officer. They will all be available for the Q

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot